Dosage Products & Reviews

Fine comminution and sieving in one unit

High performance in minimum space

Proveris’s SprayVIEW® instrumentation established the standard now recommended by the FDA for automated spray pattern and plume geometry measurement testing of spray and aerosol delivered drugs. The patented technology provides pharmaceutical laboratories with the instrumentation needed to conduct accurate, consistent spray pattern and plume geometry tests of nasal and oral sprays, and metered dose inhalers. Features & Ben…

High-speed and versatile

Efficient premium fine grinding

Our HybridSPE ® -PLus plates effectively remove phospholipids and proteins from biological matrices in a simple pass-through method for accurate and reproducible LC-MS analysis. Unlike other phospholipid removal SPE products on the market, the unique retention mechanism of HybridSPE ® allows for separation of even very hydrophobic analytes from phospholipid contaminants.     

Supel™ Swift HLB is a polymeric stationary phase for solid phase extraction (SPE) prior to instrumental analysis. It has both hydrophilic and lipophilic functional groups for the extraction of a broad range of compounds from aqueous samples. It retains analytes having diff erent polarities and Log P values due to its hydrophilic and lipophilic balance (HLB) property.

The Ustekinumab ELISA kit is intended for the quantitative determination of Ustekinumab in serum, plasma and cell culture samples.

The Adalimumab (Humira) ELISA kit is intended for the quantitative determination of Adalimumab (Humira) in serum, plasma and cell culture samples. CE IVD marked. Calibrated against NIBSC International Standards from WHO (17/236).

The Eculizumab ELISA kit is intended for the quantitative determination of Eculizumab in serum, plasma and cell culture samples.

This Degarelix ELISA kit is intended for the quantitative determination of Degarelix in serum, plasma and cell culture samples.

Immunoassay for quantitative estimation of Teriparatide in human  serum and plasma.

The Tocilizumab ELISA kit is intended for the quantitative determination of Tocilizumab in serum, plasma and cell culture samples.

The Natalizumab ELISA kit is an assay intended for the quantitative determination of Natalizumab in serum, plasma and cell culture samples.

The Vedolizumab ELISA kit is intended for the quantitative determination of Vedolizumab in serum, plasma and cell culture samples.

The Daratumumab (Darzalex) ELISA kit is an assay intended for the quantitative determination of Daratumumab (Darzalex) in serum, plasma and cell culture samples.

The Pembrolizumab ELISA kit is intended for the quantitative determination of Pembrolizumab in serum, plasma and cell culture samples. RUO only.

ELISA for the quantitative determination of Leuprolide / Leuprorelin in serum and plasma.

Immunoassay for quantitative estimation of Glatiramer Acetate in human serum and plasma. Validated for both serum and plasma samples, this Exenatide ELISA gives specific, accurate results with a ready-to-use assay format.

The Rituximab ELISA kit is intended for the quantitative determination of Rituximab in serum, plasma and cell culture samples. Validated against International NIBSC standards by WHO.

Enzyme Immunoassay for the quantitative determination of Dasatinib in serum, plasma and cell culture supernatant.

The Nivolumab ELISA kit is an assay intended for the quantitative determination of Nivolumab in serum, plasma and cell culture samples.

Enzyme Immunoassay for the quantitative determination of Anti-Atezolizumab antibodies in serum and plasma.

The Infliximab ELISA kit is intended for the quantitative determination of Infliximab in serum, plasma and cell culture samples. Validated against NIBSC international standards from WHO.

Enzyme Immunoassay for the quantitative determination of Anti-Natalizumab antibodies in serum and plasma.